ENT:LSEEntain PLC Analysis
Data as of 2026-03-12 - not real-time
£583.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Entain Plc trades at ~583 GBp, sitting just above its 20‑day SMA of 576 but well below the 50‑day (639) and 200‑day (791) averages, signaling a broader bearish backdrop. The RSI of 45 and a bearish trend direction reinforce the downside pressure, yet the MACD histogram is positive (≈5.8) and the MACD signal is flagged bullish, suggesting short‑term momentum could reverse. Volume is increasing and the price comfortably respects the identified support at 544 GBp, while the next resistance near 624 GBp provides a clear upside target. Volatility remains elevated at over 48 % on a 30‑day basis, but a beta of 0.56 indicates the stock moves less than the market, tempering systematic risk. The forward P/E of 7.7 is modest, and the DCF‑derived fair value of roughly 2,040 GBp implies an upside potential of more than 70 % from current levels. Cash flow is solid with free cash flow exceeding €1 bn, yet the balance sheet is strained by net debt of about €3.6 bn and a debt‑to‑equity ratio above 300 %. The dividend yield of 3.36 % looks attractive, but a payout ratio of 135 % raises concerns about its sustainability.
A key catalyst is the recent BetMGM revenue +33 % joint‑venture performance, where net revenue jumped 33 % YoY and EBITDA turned positive, underpinning the company’s growth narrative. Analysts have upgraded to a “strong buy” with a median target near 1,040 GBp, reflecting confidence in the US partnership and the company’s ability to convert revenue growth into cash returns. However, the gambling sector faces heightened regulatory scrutiny, especially in the UK and US, which adds a medium‑to‑high regulatory risk overlay. Geographic diversification across Europe, Australia, New Zealand and the United States mitigates single‑region exposure, placing geographic risk at a moderate level. Currency exposure is mixed, with earnings in multiple currencies versus a GBp listing, warranting a medium currency risk assessment. Liquidity appears adequate given a market cap of ~£3.7 bn and average daily volume above 2 m shares, keeping liquidity risk low. In sum, the blend of strong cash generation, attractive valuation upside, and a compelling US growth story outweighs the debt and regulatory headwinds, making Entain a compelling buy for medium to long horizons while a cautious hold is advisable in the near term.
A key catalyst is the recent BetMGM revenue +33 % joint‑venture performance, where net revenue jumped 33 % YoY and EBITDA turned positive, underpinning the company’s growth narrative. Analysts have upgraded to a “strong buy” with a median target near 1,040 GBp, reflecting confidence in the US partnership and the company’s ability to convert revenue growth into cash returns. However, the gambling sector faces heightened regulatory scrutiny, especially in the UK and US, which adds a medium‑to‑high regulatory risk overlay. Geographic diversification across Europe, Australia, New Zealand and the United States mitigates single‑region exposure, placing geographic risk at a moderate level. Currency exposure is mixed, with earnings in multiple currencies versus a GBp listing, warranting a medium currency risk assessment. Liquidity appears adequate given a market cap of ~£3.7 bn and average daily volume above 2 m shares, keeping liquidity risk low. In sum, the blend of strong cash generation, attractive valuation upside, and a compelling US growth story outweighs the debt and regulatory headwinds, making Entain a compelling buy for medium to long horizons while a cautious hold is advisable in the near term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Positive MACD histogram indicating short‑term momentum
- Increasing volume supporting potential bounce
- Support level at 544 GBp providing downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- BetMGM revenue growth of 33 % driving earnings recovery
- Forward P/E of 7.7 suggesting value
- DCF upside of >70 % indicating undervaluation
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strong free cash flow generation
- Analyst median target near 1,040 GBp
- Diversified geographic footprint reducing regional risk
Key Metrics & Analysis
Financial Health
Revenue Growth3.70%
Profit Margin-12.68%
P/E Ratio7.7
ROE-40.64%
ROA3.44%
Debt/Equity311.21
P/B Ratio419.1
Op. Cash Flow£554.2M
Free Cash Flow£1.0B
Technical Analysis
TrendBearish
RSI45.4
Support£544.00
Resistance£624.20
MA 20£576.33
MA 50£639.41
MA 200£790.85
MACDBullish
VolumeIncreasing
Fear & Greed Index78.16
Valuation
Fair Value£2,040.12
Target Price£1,028.47
Upside/Downside76.41%
GradeUndervalued
TypeGrowth
Dividend Yield3.36%
Risk Assessment
Beta0.56
Volatility48.42%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.